Bank of New York Mellon Corp - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 76 filers reported holding KRYSTAL BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$11,393,520
+0.4%
98,220
+1.7%
0.00%
+50.0%
Q2 2023$11,342,718
+78.1%
96,616
+21.4%
0.00%
+100.0%
Q1 2023$6,369,814
-2.1%
79,563
-3.1%
0.00%0.0%
Q4 2022$6,503,645
+10.1%
82,096
-3.2%
0.00%0.0%
Q3 2022$5,908,000
+12.1%
84,792
+5.6%
0.00%0.0%
Q2 2022$5,270,000
-8.9%
80,263
-7.6%
0.00%0.0%
Q1 2022$5,782,000
-0.9%
86,895
+4.1%
0.00%0.0%
Q4 2021$5,837,000
+46.3%
83,451
+9.2%
0.00%0.0%
Q3 2021$3,991,000
-16.9%
76,429
+8.2%
0.00%0.0%
Q2 2021$4,802,000
-7.5%
70,630
+4.8%
0.00%0.0%
Q1 2021$5,189,000
+28.1%
67,368
-0.2%
0.00%0.0%
Q4 2020$4,050,000
+50.7%
67,480
+8.1%
0.00%0.0%
Q3 2020$2,687,000
+10.1%
62,415
+5.9%
0.00%0.0%
Q2 2020$2,440,000
-13.5%
58,913
-9.7%
0.00%0.0%
Q1 2020$2,821,000
-24.6%
65,220
-3.5%
0.00%0.0%
Q4 2019$3,743,000
+48.5%
67,589
-6.9%
0.00%0.0%
Q3 2019$2,521,000
-3.3%
72,616
+12.2%
0.00%0.0%
Q2 2019$2,606,000
+279.3%
64,726
+210.2%
0.00%
Q1 2019$687,000
+33.9%
20,867
-15.4%
0.00%
Q4 2018$513,00024,6770.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 1,913,280$153,177,1976.65%
Frazier Life Sciences Management, L.P. 945,407$75,689,2845.48%
S Squared Technology, LLC 108,215$8,663,6935.14%
Nicholas Investment Partners, LP 374,718$29,999,9232.28%
Avoro Capital Advisors LLC 1,750,000$140,105,0002.08%
Artal Group S.A. 412,082$32,9911.96%
First Light Asset Management, LLC 195,980$15,690,1591.41%
Integral Health Asset Management, LLC 85,000$6,805,1001.37%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 61,000$4,883,6601.36%
Hood River Capital Management LLC 447,393$35,818,0001.16%
View complete list of KRYSTAL BIOTECH INC shareholders